Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Daniel Krewski, Robert A Yokel, Evert Nieboer, David Borchelt, Joshua Cohen, Jean Harry7, Sam Kacew2,8, Joan Lindsay9, Amal M Mahfouz10, Virginie Rondeau11 1Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada, McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Ontario, Canada, College of Pharmacy and Graduate Center for Toxicology, University of Kentucky Medical Center, Kentucky, USA, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada, Institute of Community Medicine, University of Tromsø, Norway, 5SantaFe Health Alzheimer’s Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, USA, Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, USA, 7National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada, Aging-Related Diseases Section, Surveillance Division, Public Health Agency of Canada, Ottawa, Ontario, Canada, 10United States Environmental Protection Agency, Washington DC, USA, INSERM E0338 (Biostatistic), Université Victor Segalen Bordeaux 2, Bordeaux, France